Hemorrhagic stroke
This presentation is the property of its rightful owner.
Sponsored Links
1 / 63

Hemorrhagic Stroke PowerPoint PPT Presentation


  • 775 Views
  • Uploaded on
  • Presentation posted in: General

Hemorrhagic Stroke. Lourdes James MS ACNP-BC CCRN The Johns Hopkins Hospital AACN Progressive Care Pathways Conference September 2013. Learning Outcomes. Identify the risk factors of hemorrhagic stroke Describe the etiology of hemorrhagic stroke

Download Presentation

Hemorrhagic Stroke

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Hemorrhagic stroke

Hemorrhagic Stroke

Lourdes James MS ACNP-BC CCRN

The Johns Hopkins Hospital

AACN Progressive Care Pathways Conference

September 2013


Learning outcomes

Learning Outcomes

  • Identify the risk factors of hemorrhagic stroke

  • Describe the etiology of hemorrhagic stroke

  • Relate the pathophysiological processes of hemorrhagic stroke to progressive care patient pathways and nursing care


Stroke definitions

Stroke Definitions

  • Stroke

    • Any damage to brain or CNS structures caused by abnormalities of the blood supply

    • Acute-onset of symptoms

  • Cerebrovascular Accident (CVA)

    • More general term

    • Does not define time (acute/chronic) in relation to brain injury


Stroke classification

Stroke Classification

  • Ischemic

    • 87% of all strokes

  • Hemorrhagic

    • Intracerebral Hemorrhage (ICH) – 10 to 15% of all strokes

    • Subarachnoid Hemorrhage (SAH) – 3%

    • Intraventricular Hemorrhage (IVH)

      • Rarely isolated

      • Typically extension of ICH

        • Occurs in 45% of patients with spontaneous ICH


Intracerebral hemorrhage

Intracerebral Hemorrhage


Ich definition

ICH: Definition

  • Non-traumatic, abrupt onset of severe headache, altered level of consciousness, or focal neurological deficit associated with a focal collection of blood within the brain parenchyma which is not due to trauma or hemorrhagic conversion of a cerebral infarction


Hemorrhagic stroke

Intraventricular Hemorrhage


Ich epidemiology

ICH: Epidemiology

  • Incidence rates in Western Hemisphere

    • 10 – 30 cases/100,000

  • Incidence rates are higher in Eastern Asia

  • Incidence greater in men than women


Ich location

ICH: Location

  • Location varies in populations

  • Deep cerebral hemorrhage

    • Most common in US, Europe and Australia

  • Lobar hemorrhages

    • Second to deep cerebral hemorrhage

    • ≅15% of ICHs

  • Cerebellar hemorrhages

    • ≅10% of ICHs

  • Brainstem hemorrhages

    • ≅5 – 10% of ICHs


Hemorrhagic stroke

A: Lobar: originating from penetrating cortical branches of the anterior, middle, or posterior cerebral arteries

B: Basal ganglia: originating from ascending lenticulostriate branches of the middle cerebral artery

C: Thalamus: originating from ascending thalmogeniculate branches of the posterior cerebral artery

D: Pons: originating from paramedian branches of the basilar artery

E: Cerebellum: originating from penetrating branches of the posterior inferior, anterior inferior, or superior cerebellar arteries


Ich risk factors

ICH: Risk factors

  • Hypertension

  • Age

  • Race

  • Cerebral Amyloid Angiopathy

  • Aneurysms/Vascular Malformations

  • Apolipoprotein E and CAA

  • Anticoagulants/Thrombolytics

  • Antiplatelets

  • Cerebral Microbleeds

  • Prior Cerebral Infarction

  • Hypocholesterolemia

  • Heavy Alcohol Use

  • Tobacco Use

  • Diabetes

  • Heritability


Ich etiology

ICH: Etiology

  • Hypertension

  • IVDA/Cocaine Use

  • Vascular malformations

    • AVM

    • Aneurysm

    • Cavernous angioma

  • Amyloid angiopathy

  • Coagulopathies

  • Neoplasm

  • Trauma


Ich pathophysiology

ICH: Pathophysiology

  • Damage to small penetrating arteries and arterioles (HTN)

  • Rupture of small penetrating arteries

  • Local pressure effect on surrounding capillaries and arterioles

  • Accumulation of hematoma


Ich clinical presentation

ICH: Clinical Presentation

  • Severe headache

  • Focal neurological deficits

  • Coma or decreased LOC

  • SBP > 200 mmHg

  • Vomiting

  • Given that symptoms are non-specific,

  • neuroimaging is a necessity


Ich neuroimaging

ICH: Neuroimaging

  • CT or MRI to distinguish between ischemic or hemorrhagic stroke

  • Hematoma expansion?

    • CTA or contrast-enhanced CT

  • Underlying structural lesions?

    • CTA/CTV, contrast-enhanced CT, contrast-enhanced MRI, MRA/MRV

  • Underlying vascular anomaly?

    • Cerebral angiography if high suspicion


Ich symptom progression

ICH: Symptom Progression

  • Worsening of symptoms during first 24 – 48 hours:

    • Continuation of bleeding

    • Hematoma enlargement

    • Cerebral edema

    • Herniation


Ich hematoma expansion

ICH: Hematoma Expansion

  • High rate of early neurologic deterioration due to bleeding occurring for hours after symptom onset

  • Head CT within 3 hours after symptom onset:

    • 28 – 38% have hematoma expansion of > 1/3

  • Predictive of neurologic deterioration and increased morbidity and mortality


Ich inpatient management

ICH: Inpatient Management

  • Obtain Hemostasis

    • Severe coagulation factor deficiency or thrombocytopenia

      • Replace factors and/or platelets

    • If INR elevated due to oral anticoagulation:

      • Hold warfarin (Coumadin)

      • Replace Vitamin K dependent factors (IV Vitamin K recommended)

      • Correct INR


Ich inpatient m anagement

ICH: Inpatient Management

  • General Monitoring

    • Initial monitoring in ICU

  • Blood Pressure (BP) Management

    • Incomplete efficacy evidence at present until ongoing trials of BP intervention

    • Patients with Systolic BP (SBP) 150 – 220mmHg, acute lowering to SBP < 140mmHg probably safe (Class IIa, Level B)


Hemorrhagic stroke

Stroke. 2010;41:2108-2129


Ich inpatient m anagement1

ICH: Inpatient Management

  • Temperature Management

    • Duration of fever linked to outcome, prognostic factor in patients surviving first 72H

    • Maintain normothermia

  • Seizure Prophylaxis

    • Treat with anti-epileptic drugs (AED) for patients with clinical seizures, electrographic seizures + change in MS

    • Prophylaxis with AED not recommended (Class III, Level B)


Ich inpatient m anagement2

ICH: Inpatient Management

  • Glycemic Control

    • Maintain normoglycemia

  • DVT prophylaxis

    • Intermittent pneumatic compression + elastic stockings

    • May consider low-dose LMWH after ICH stability established and 1-4 days from onset (Class IIb, Level B)


Ich inpatient m anagement3

ICH: Inpatient Management

  • Code Status

    • Aggressive full care early after ICH onset

    • Postponement of new DNR orders until at least the second full day of hospitalization is probably recommended

      (Class IIa,Level B)

    • Does not include patients with pre-existing DNR status


Icp monitoring treatment

ICP Monitoring & Treatment

  • ICP Monitoring Indications (Class IIb, Level C)

    • GCS ≤ 8

    • Transtentorial herniation

    • Significant IVH or hydrocephalus

  • CPP of 50 – 70 mmHg (Class IIb, Level C)

  • Ventricular drainage reasonable for treatment of hydrocephalus in patients with decreased LOC (Class IIa, Level B)


Ich surgical interventions

ICH: Surgical Interventions

  • Indications for Surgical Removal of Hemorrhage

    • Usefulness of surgery uncertain (Class IIb, Level C)

    • Cerebellar hemorrhage with evidence of neurological deterioration, or brain stem compression, and/or hydrocephalus (Class I, Level B)

    • Lobar clots > 30mL and within 1 cm of surface, supratentorial clot evacuation via craniotomy may be considered (Class IIb, Level B)


Ich recurrence prevention

ICH: Recurrence Prevention

  • BP Management

    • BP should be well-controlled after acute ICH

      • BP <140/90mmHg, <130/90mmHg if DM or CKD (Class IIa, Level B)

  • Anticoagulation

    • Avoid long-term anticoagulation for non-valvular atrial fibrillation after lobar ICH (Class IIa, Level B)

    • Anticoagulation after non-lobar ICH and anti-platelet therapy after all ICH might be considered when definite indication (Class IIB, Level B)


Ich recurrence prevention1

ICH: Recurrence Prevention

  • Avoidance of heavy alcohol usage (Class IIa, Level B)

  • Insufficient data to recommend restrictions for:

    • Statins

    • Physical activity

    • Sexual activity


Ich nursing considerations

ICH: Nursing Considerations

  • Neurological monitoring

    • Change in exam?

      • Hematoma expansion?

      • Worsening cerebral edema/herniation?

      • Increased ICP?

      • Seizure?

  • ICP/Cerebral perfusion pressure (CPP) monitoring

  • BP management and hemodynamic monitoring

  • Airway maintenance

  • Maintain normothermia

  • Maintain normoglycemia

  • Prevention of complications


Subarachnoid hemorrhage

Subarachnoid Hemorrhage


Subarachnoid hemorrhage sah

Subarachnoid Hemorrhage (SAH)

  • Bleeding into the subarachnoid space (between the arachnoid layer and pia mater)


Sah etiology

SAH: Etiology

  • Trauma

    • Most common

  • Ruptured cerebral aneurysm

    • Most described in literature

    • Aneurysmal subarachnoid hemorrhage (aSAH)


Asah epidemiology

aSAH: Epidemiology

  • US incidence: 9.7/100,000

  • 14.5 discharges/100,000

  • US mean mortality rate: 32%

    • Death occurs in 12-15% of cases before reaching hospital

    • True incidence may be higher?

  • Average age of onset ≥ 50

  • Incidence higher in females than males

  • African Americans and Hispanics have higher incidence


Asah behavioral risk factors

aSAH: Behavioral Risk Factors

  • Hypertension

  • Tobacco Use

  • Alcohol Abuse

  • Sympathomimetic drugs (cocaine)


Asah non modifiable risk factors

aSAH: Non-modifiable Risk Factors

  • Female gender

  • Unruptured aneurysm

    • Symptomatic

    • Larger in size

    • Posterior communicating artery or vertebrobasilar location

  • Previous aSAH

  • Familial aneurysms

    • At least 1 first-degree relative, especially ≥ 2 first degree relatives

  • Genetic syndromes


Asah clinical presentation

aSAH: Clinical Presentation

  • “Worst headache of life”

    • Described by ≈ 80% of patients

  • Onset of headache may be associated with:

    • Nausea

    • Vomiting

    • Nucchal rigidity

    • Photophobia

    • Focal neurological deficits

    • Loss of consciousness


Asah diagnosis

aSAH: Diagnosis

  • Clinical presentation

    • High level of suspicion with acute onset severe headache

  • Neuroimaging

    • CT for suspected SAH

      • Lumbar Puncture (LP) if CT negative

    • CTA may be used to detect aneurysm

      • if inconclusive, will need cerebral angiogram

    • Cerebral angiography for +SAH to identify presence of aneurysm if not detected on noninvasive angiogram

    • MRI may be reasonable for diagnosis, would still need LP


Asah prognosis

aSAH: Prognosis

  • SAH Grading Scales

    • Hunt and Hess Scale

    • Fisher Scale

  • Degree of neurological impairment associated with prognosis


Asah prevention of rebleed

aSAH: Prevention of Rebleed

  • BP Management (SBP < 160mmHg)

  • Bedrest

  • Antifibrinolytic therapy?

    • For patients with unavoidable delay in surgical/endovascular treatment

    • < 72 hours of therapy

    • tranexamic acid or aminocaproic acid is reasonable


Asah prevention of rebleed1

aSAH: Prevention of Rebleed

  • Surgical/endovascular treatment of ruptured aneurysm

    • Surgical clipping of cerebral aneurysm

    • Stent/coiling of cerebral aneurysm

  • Should be performed as early as possible

  • Complete obliteration recommended


Asah complications

aSAH: Complications

  • Cerebral Vasospasm and Delayed Cerebral Ischemia (DCI)

  • Hydrocephalus

  • Hyponatremia and Volume Contraction

  • Seizures

  • Cerebral edema

  • Rebleed

  • Neurogenic Stress Cardiomyopathy


Asah cerebral v asospasm dci

aSAH: Cerebral Vasospasm/DCI

  • Clinical vs Angiographic Vasospasm

  • Transcranialdoppler (TCD)

  • Management:

    • Oral nimodipine (Nimptop)

    • Maintain euvolemia

    • Prophylactic hypervolemia not recommended

    • Induced HTN recommended for DCI, unless HTN at baseline or poor cardiac status


Asah cerebral v asospasm dci1

aSAH: Cerebral Vasospasm/DCI

  • Symptomatic Vasospasm

    • Triple-H Therapy

      • Hypervolemia

      • Hypertension

      • Hemodilution

    • Cerebral angioplasty/IA vasodilator therapy


Asah hydrocephalus

aSAH: Hydrocephalus

  • CSF diversion

    • Temporary or permanent

  • Ventriculostomy

    • Ventriculomegaly and LOC


Asah seizures

aSAH: Seizures

  • Prophylactic AED therapy in immediate posthemorrhagic period

  • Routine long-term use of AED not recommended, unless otherwise indicated


Asah hyponatremia volume c ontraction

aSAH: Hyponatremia & Volume Contraction

  • Avoid hypotonic solutions and intravascular volume contraction

  • Volume contraction treatment

    • Isotonic solutions

  • Hyponatremia treatment

    • Hypertonic solutions

    • Fludrocortisone (Florinef)


Asah hyponatremia volume c ontraction1

aSAH: Hyponatremia & Volume Contraction

  • Volume status monitoring

    • Central Venous Pressure (CVP)

    • Pulmonary Artery Wedge Pressure (PAWP)

    • Fluid balance

    • Body weight


Asah neurogenic stress cardiomyopathy

aSAH: Neurogenic Stress Cardiomyopathy

  • Secondary cardiomyopathy and/or regional wall motion abnormality (RWMA) associated with intracranial hemorrhage

    • Most common after aneurysmal SAH

  • Reversible cardiomyopathy

  • No evidence of underlying obstructive CAD


  • Asah neurogenic stress cardiomyopathy1

    aSAH: Neurogenic Stress Cardiomyopathy

    • Epidemiology:

      • Nearly 20 – 30% of patients with SAH have evidence of a secondary cardiomyopathy and/or regional wall motion abnormality (RWMA)

      • Pulmonary edema noted in approximately 10% of patients with SAH

      • Sudden death occurs in 12% of patients with SAH


    Asah neurogenic stress cardiomyopathy2

    aSAH: Neurogenic Stress Cardiomyopathy

    • Clinical Findings:

      • ECG changes

      • Arrhythmias

      • RWMA

      • Elevated cardiac enzymes

      • BNP elevation

      • Chest x-ray abnormalities


    Asah management of other c omplications

    aSAH: Management of Other Complications

    • DVT prophylaxis

    • Anemia

      • Treat with PRBC for those with concern for cerebral ischemia

      • Optimal Hgb goal not established

    • Maintain normothermia

    • Avoid hypoglycemia


    Asah nursing considerations

    aSAH: Nursing Considerations

    • Neurological monitoring

      • Change in exam?

        • Cerebral vasospasm?

        • Hydrocephalus?

        • Seizure?

    • ICP/CPP monitoring

    • Monitoring the airway

    • Evaluating hemodynamic status

    • Monitoring fluid and electrolytes

    • Pain management

    • Preventing complications

    • Allow for calm environment


    Questions

    Questions?


    Hemorrhagic stroke

    Speaker Contact Information:Lourdes James MS ACNP-BC CCRNThe Johns Hopkins HospitalNeurosciences Critical [email protected]


  • Login